Autoimmune Diseases  >>  Synacthen Depot (cosyntropin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Synacthen Depot (cosyntropin) / Novartis, Mallinckrodt, Alliance
ACTHiMeN, NCT00694863: Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy

Completed
2
20
Europe
tetracosactide hexacetaat, Synacthen Depot, long-acting synthetic ACTH
Radboud University Medical Center, Dutch Kidney Foundation
Idiopathic Membranous Nephropathy
12/10
12/12

Download Options